Further mechanistic investigation defined that Axl inhibition reprograms the immunological microenvironment leading to the increased proliferation, activation and effector function of tumor-infiltrating CD4+ and CD8+T cells possibly through preferential accumulation and activation of CD103+ cDCs, which is in favor of antitumor immune response. This evidence concerns the gene AXL and neoplasm.